Dr. Grey AI

Osteoporosis

Osteoporosis is a condition of having weak and brittle bones. The main goal for people with osteoporosis is to prevent bone fractures by strengthening the bones and by avoiding falls.

Quick Answer

What it is

Osteoporosis is a condition of having weak and brittle bones. The main goal for people with osteoporosis is to prevent bone fractures by strengthening the bones and by avoiding falls.

Key findings

  • Grade A: Vertebral Fracture Risk (Romosozumab (Evenity))
  • Grade A: Clinical Fracture Risk (Romosozumab (Evenity))
  • Grade A: Total Hip BMD (Romosozumab (Evenity))

Safety

  • ARCH showed 48% lower risk vs alendronate at 24 months.
  • FRAME trial showed lower risk of clinical fractures (composite of nonvertebral and symptomatic vertebral) with romosozumab vs placebo at 12 months.
  • Substantial gains in femoral neck BMD with romosozumab, contributing to reduced hip fracture risk.
ℹ️ Quick Facts

Quick Facts: Osteoporosis

  • Supplements Studied:9
  • Research Trials:8
  • Total Participants:62,544
  • Top Supplement:Vitamin D (B)
8 trials
62,544 ppts
9 supps · 42 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

Vitamin DB
1000-4000 IU daily (target serum 30-50 ng/mL)

Enhances intestinal calcium absorption, regulates osteoblast/osteoclast balance, and is essential for proper bone mineralization

22 studies | 5,522 participants
Vitamin KB
100-200mcg K2 (MK-7 form) daily

Activates osteocalcin (essential bone protein) through carboxylation, directs calcium into bones rather than soft tissues, and supports bone matrix formation

9 studies | 4,800 participants

Supporting Stack (Tier 2)

Horny Goat Weed (Epimedium)B
500-1000mg daily (standardized to 10% icariin)

Icariin stimulates osteoblast activity, inhibits osteoclast-mediated bone resorption, and has mild phytoestrogenic effects supporting bone density

10 studies | 956 participants
Soy Protein (Isoflavones)C
40-80mg isoflavones daily

Isoflavones (genistein, daidzein) bind estrogen receptors in bone, stimulating osteoblast activity and inhibiting osteoclast formation

4 studies | 393 participants

How It Works

Osteoporosis develops when bone breakdown (by cells called osteoclasts) outpaces bone formation (by osteoblasts). This imbalance accelerates after menopause due to declining estrogen, but can also be caused by aging, nutritional deficiencies, certain medications, and sedentary lifestyle. The result is porous, fragile bones prone to fractures.

•Vitamin D is fundamental for bone health—without adequate vitamin D, your body can only absorb 10-15% of dietary calcium. With sufficient vitamin D, absorption increases to 30-40%. Vitamin D also directly regulates bone cells, telling osteoblasts to build bone. Most people are deficient, especially in northern latitudes. Studies involving over 5,500 participants show vitamin D improves bone mineral density.
•Vitamin K2 works as a 'traffic director' for calcium. It activates a protein called osteocalcin that binds calcium into bone. Without K2, calcium may deposit in arteries instead of bones. The MK-7 form from fermented foods (natto) has the longest half-life. Large studies with nearly 5,000 participants show K2 improves bone density and reduces fracture risk.
•Horny Goat Weed (Epimedium) contains icariin, a compound that stimulates bone-building cells while inhibiting bone-destroying cells. It also has mild estrogen-like effects, which is particularly beneficial for postmenopausal women. Chinese medicine has used it for bone health for centuries, and modern studies validate its effects.
•Soy Isoflavones are plant estrogens that can partially compensate for declining estrogen in postmenopausal women, supporting bone density maintenance.

Expected timeline: Bone is slow to change—improvements in bone mineral density typically take 6-12 months of consistent supplementation to measure. However, fracture risk reduction can begin earlier as bone quality improves.

Important notes: Calcium intake (1000-1200mg daily from food and/or supplements) is essential alongside these supplements. Weight-bearing exercise is crucial—supplements cannot replace physical activity for bone health. Fall prevention is equally important in osteoporosis management.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
A
Vertebral Fracture Risk
FRAME trial showed 73% reduction in new vertebral fractures at 12 months (0.5% vs 1.8% placebo, P<0.001). ARCH showed 48% lower risk vs alendronate at 24 months.
large↓Improves
A
Clinical Fracture Risk
FRAME trial showed lower risk of clinical fractures (composite of nonvertebral and symptomatic vertebral) with romosozumab vs placebo at 12 months.
moderate↓Improves
A
Total Hip BMD
ARCH showed 6.3% increase in total hip BMD at 12 months with romosozumab vs 2.9% with alendronate (P<0.001).
large↑Improves
A
Lumbar Spine BMD
Significant increases in lumbar spine BMD with romosozumab treatment, greater than placebo, alendronate, and teriparatide at 12 months.
large↑Improves
A
Femoral Neck BMD
Substantial gains in femoral neck BMD with romosozumab, contributing to reduced hip fracture risk.
large↑Improves
A
Hip Fracture Risk
ARCH trial showed reduced hip fracture risk with romosozumab-to-alendronate sequence vs alendronate alone.
moderate↓Improves
A
Vertebral Fracture Risk
FREEDOM trial showed 68% reduction in new vertebral fractures (2.3% vs 7.2% placebo, P<0.001) over 3 years in postmenopausal women.
large↓Improves
A
Hip Fracture Risk
FREEDOM trial showed 40% reduction in hip fractures (0.7% vs 1.2% placebo, HR 0.60, P=0.04) over 3 years.
moderate↓Improves
A
Nonvertebral Fracture Risk
FREEDOM trial showed 20% reduction in nonvertebral fractures (6.5% vs 8.0% placebo, HR 0.80, P=0.01) over 3 years.
moderate↓Improves
A
Lumbar Spine BMD
10-year extension showed 21.7% increase in lumbar spine BMD from baseline, with continued gains without plateau.
large↑Improves
A
Total Hip BMD
10-year extension showed 9.2% increase in total hip BMD from baseline with sustained improvement.
large↑Improves
A
Femoral Neck BMD
10-year extension showed 9.0% increase in femoral neck BMD from baseline.
large↑Improves
A
Vertebral Fracture Risk
Meta-analysis showed 70% reduction in vertebral fracture risk (RR 0.30, 95% CI: 0.21-0.44). TOWER trial showed 80% reduction with cumulative incidence of 3.1% vs 14.5% placebo.
large↓Improves
A
Non-Vertebral Fracture Risk
Meta-analysis showed 38% reduction in non-vertebral fracture risk (RR 0.62, 95% CI: 0.44-0.87) in postmenopausal women with osteoporosis.
moderate↓Improves
A
Lumbar Spine BMD
24 months of treatment increased lumbar spine BMD by 10.7-13.4%, with 83% of patients showing >3% BMD increase.
large↑Improves
A
Femoral Neck BMD
24 months of treatment increased femoral neck BMD by 2.7-3.3%, with 40% of patients showing significant response.
moderate↑Improves
A
Total Hip BMD
24 months of treatment increased total hip BMD by 3.0-3.7% from baseline.
moderate↑Improves
A
Glucocorticoid-Induced Osteoporosis
Teriparatide is superior to bisphosphonates for glucocorticoid-induced osteoporosis, with greater BMD increases at spine and hip.
moderate↑Improves
A
Vertebral Fracture Risk
PROOF trial showed 33% reduction in new vertebral fractures with 200 IU nasal spray (RR 0.67, P=0.03) over 5 years. 36% reduction in women with 1-5 prevalent fractures.
moderate↓Improves
A
Acute Fracture Pain
Multiple RCTs demonstrate significant analgesic effect in acute osteoporotic vertebral compression fractures, with reduced pain scores and analgesic requirements.
moderate↓Improves
B
Bone Mineral Density
Calcitonin produces modest increases in lumbar spine BMD, though effects are less pronounced than bisphosphonates or other antiresorptives.
small↑Improves
A
Vertebral Fracture Risk
ACTIVE trial: 86% reduction in new vertebral fractures vs placebo (P<0.001)
large↓Improves
A
Non-Vertebral Fracture Risk
ACTIVE trial: 43% reduction in non-vertebral fractures vs placebo
moderate↓Improves
A
Lumbar Spine BMD
8.48% increase at 12 months vs 1.17% placebo in men (ATOM trial)
large↑Improves
A
Total Hip BMD
2.14% increase vs 0.01% placebo at 12 months
moderate↑Improves
A
Femoral Neck BMD
2.98% increase vs 0.15% placebo at 12 months
moderate↑Improves
B
Bone Mineral Density
Small Improvement
22 studies
small↑Improves
?
Fracture Risk
12 studies
↑Worsens
?
Bone-specific Alkaline Phosphatase
1 study
↑Improves
B
Bone Mineral Density
Small Improvement
10 studies
small↑Improves
C
Circulating Alkaline Phosphatase
Small Decrease
1 study
small↓Improves
?
Interleukin 6
3 studies
↓Improves
?
Estrogen
2 studies
↑Worsens
?
Serum Phosphorus
2 studies
↑Worsens
?
Pain
1 study
↓Improves
?
Serum Calcium
1 study
↑Improves
B
Bone Mineral Density
Moderate Improvement
9 studies
moderate↑Improves
?
Fracture Risk
12 studies
↑Worsens
?
Estrogen
1 study
↑Worsens
?
Total cholesterol
1 study
↓Improves
?
Weight
1 study
↓Improves
?
Bone Mineral Density
4 studies
↑Improves

Related Conditions

Bone Health

8 shared supplements · 82 outcomes

Bone health refers to the strength of bones and the quality of bone structure. Bone health is usually measured as bone mineral density. Bone health is affected by nutrient intake, hormonal regulation, exercise, and age, among other factors.

Type 2 Diabetes

3 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Metabolic Health

3 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

Menopause

3 shared supplements · 223 outcomes

Menopause is the stage of life when menses permanently cease, and the reproductive system no longer performs functions related to fertility. A woman is considered to have entered menopause after menses have stopped for 12 months.

Surgical Recovery

2 shared supplements · 43 outcomes

Surgical recovery refers to physiological endpoints after surgery including recovery time and adverse events including morbidity and mortality, as well as the presence of physical pain, physical comfort with everyday activities, physical independence, psychological support, and emotional well-being.

2 shared supplements · outcomes

Muscle Size & Strength

2 shared supplements · 334 outcomes

This page on muscle size and strength covers strategies to maximize muscle gain and strength gain. There is notable overlap in nutrition and supplementation strategies to facilitate these two goals, but there is some divergence in the best type of exercise. A larger muscle tends to be a stronger muscle.

Metabolic Syndrome

2 shared supplements · 391 outcomes

Metabolic syndrome refers to a group of cardiometabolic risk factors: abdominal obesity, high blood pressure, high fasting blood sugar, high blood triglycerides, and low HDL-C. If a person has at least three of these, they have metabolic syndrome.